Last reviewed · How we verify

NCT06942221: DIGNITY - HF

Digital Solutions in Heart Therapy (DIGNITY)

Recruiting now NA Last updated 2 December 2025
What this trial tests

NA trial testing usual care in Heart Failure With Reduced Ejection Fraction in 140 participants. Currently enrolling.

Timeline
17 July 2025
Primary endpoint
31 December 2026
31 December 2026

Quick facts

Lead sponsorUniversity Hospital, Basel, Switzerland
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment140
Start date17 July 2025
Primary completion31 December 2026
Estimated completion31 December 2026
Sites1 location across Switzerland

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Basel, Switzerland

Who can join

18 and older, any sex, with Heart Failure With Reduced Ejection Fraction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to assess the safety and effectiveness of telemedicine guided strategy on guideline-directed medical therapy (GDMT) optimization in hospitalized patients with heart failure in comparison to usual care in Switzerland.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of usual care

Trials testing the same drug.

Other recruiting trials for Heart Failure With Reduced Ejection Fraction

Currently open trials in the same condition.

Other University Hospital, Basel, Switzerland trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06942221.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing